MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,538 Cr | ₹848 Cr | ₹576 Cr | ₹388 Cr | ₹331 Cr |
What is the latest Sundry Debtors ratio of MANKIND PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹1,538 Cr |
| Mar2024 | ₹848 Cr |
| Mar2023 | ₹576 Cr |
| Mar2022 | ₹388 Cr |
| Mar2021 | ₹331 Cr |
How is Sundry Debtors of MANKIND PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,538 Cr | 81.35 | |
| Mar2024 | ₹848 Cr | 47.16 | |
| Mar2023 | ₹576 Cr | 48.50 | |
| Mar2022 | ₹388 Cr | 17.41 | |
| Mar2021 | ₹331 Cr | - | |
Compare Sundry Debtors of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹93,703.5 Cr | 1.6% | 14.2% | -11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.6% |
14.2% |
-11% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses